MARKET

KLTO

KLTO

Klotho Neurosciences, Inc.
NASDAQ
0.2890
-0.0131
-4.34%
After Hours: 0.2945 +0.0055 +1.90% 19:39 12/31 EST
OPEN
0.3000
PREV CLOSE
0.3021
HIGH
0.3057
LOW
0.2763
VOLUME
1.30M
TURNOVER
--
52 WEEK HIGH
3.910
52 WEEK LOW
0.1135
MARKET CAP
20.96M
P/E (TTM)
-0.8854
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KLTO last week (1222-1226)?
Weekly Report · 12/29/2025 10:18
Weekly Report: what happened at KLTO last week (1215-1219)?
Weekly Report · 12/22/2025 10:18
Weekly Report: what happened at KLTO last week (1208-1212)?
Weekly Report · 12/15/2025 10:25
Klotho Neurosciences Enters Securities Purchase Agreement
TipRanks · 12/08/2025 22:00
Klotho Neuroscience Sells $15M in Series C Preferred Stock to Sigma9 Capital
Reuters · 12/08/2025 21:32
Weekly Report: what happened at KLTO last week (1201-1205)?
Weekly Report · 12/08/2025 10:24
KLOTHO NEUROSCIENCES INC - FILES PROSPECTUS FOR OFFER AND RESALE BY SELLING STOCKHOLDERS OF UP TO 34.9 MLN SHARES OF COMMON STOCK
Reuters · 12/05/2025 22:19
Weekly Report: what happened at KLTO last week (1124-1128)?
Weekly Report · 12/01/2025 10:19
More
About KLTO
Klotho Neurosciences, Inc. develops essential medicines for the treatment of chronic diseases such as cancer, cardiovascular, and neurodegenerative disorders. The Company's licensed platforms, namely, a generic drug portfolio and a biosimilar biologics platform uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Its primary focus is the advancement of a sustainable portfolio of cell and gene therapy product candidates for age-associated neurologic diseases, both rare orphan diseases and diseases in larger patient populations. The Company's two lead gene therapy product candidates are KLTO-101 (AAV9-CMV-sKL) for the treatment or prevention of Alzheimer’s disease, and KLTO-202 (AAVmyo-Des-sKL) gene therapy product for the treatment and prevention of Lou Gehrig’s disease (amyotrophic lateral sclerosis).

Webull offers Klotho Neurosciences Inc stock information, including NASDAQ: KLTO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KLTO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KLTO stock methods without spending real money on the virtual paper trading platform.